Evidence map›Paper›PMID 39378147›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Systematic Analysis and Network Mapping of Disease Associations in Autoimmune Polyglandular Syndrome.

Greta Pham-Dobor, Peter Kaltenecker, Viktoria Temesfoi, Laszlo Bajnok, Orsolya Nemes, Beata Bodis, Emese Mezosi

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Greta Pham-DoborFirst Department of Medicine, Clinical Centre, Medical School, University of Pecs, Pecs 7624, Hungary.ORCID 0009-0007-1578-1312
Peter KalteneckerSzentagothai Research Centre, University of Pecs, Pecs 7624, Hungary.
Viktoria TemesfoiSzentagothai Research Centre, University of Pecs, Pecs 7624, Hungary.
Laszlo BajnokFirst Department of Medicine, Clinical Centre, Medical School, University of Pecs, Pecs 7624, Hungary.
Orsolya NemesFirst Department of Medicine, Clinical Centre, Medical School, University of Pecs, Pecs 7624, Hungary.
Beata BodisFirst Department of Medicine, Clinical Centre, Medical School, University of Pecs, Pecs 7624, Hungary.
Emese MezosiFirst Department of Medicine, Clinical Centre, Medical School, University of Pecs, Pecs 7624, Hungary.ORCID 0000-0001-9367-3877

Funding

Thematic Excellence Program 2021 RRF-2.3.1-21-2022-00012
6 · The paper itself

Abstract

backgroundThe purpose of our work was to provide a data-driven perspective to autoimmune polyglandular syndrome (APS), a complex autoimmune disorder, supplementing traditional clinical observations.

methodsMedical records of 7559 patients were analyzed, and autoimmune origin was proved in 3180 cases of which 380 (12%) had APS. Associations of component disorders were investigated by computational methods to reveal typical patterns of disease development.

resultsTwenty-eight distinct autoimmune disorders were diagnosed forming 113 combinations. The 10 most frequent combinations were responsible for 51.3% of cases. Hashimoto's thyroiditis (HT) and Graves' disease (GD) were differentiated as the main cornerstones of APS, sharing several comorbidities. HT was the most common manifestation (67.4%), followed by GD (26.8%) and type 1 diabetes mellitus (T1D) (20.8%). APS started significantly earlier in men than in women. Thyroid autoimmunity was frequently linked to gastrointestinal and systemic manifestations, and these patterns of associations substantially differed from that of T1D, Addison's disease, or coeliac disease when present as first manifestations, suggesting the possibility of a common biological cause.

conclusionAPS is more frequent than reported. Classifying APS requires a shift of perspective toward disease associations rather than disorder prevalence.

Indexed as

Polyendocrinopathies, AutoimmuneAdolescentAdultAgedChildChild, PreschoolComorbidityDiabetes Mellitus, Type 1FemaleGraves DiseaseHashimoto DiseaseHumansMaleMiddle AgedYoung Adultautoimmune polyglandular syndromeautoimmune thyroid disordersautoimmunitiesdiabetesmultiple autoimmune syndromesnetwork mappingsystemic analysis

Identifiers

PMID39378147
PMCPMC12086395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.